Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 17, 2023 01:28 ET | Source: Coloplast A/S

Coloplast A/S - Selskabsmeddelse nr. 04/2023 - Regnskabsmeddelelse, 9M 2022/2023

9M 2022/23Delårsrapport, 9M 2022/231. oktober 2022 – 30. juni 2023 Coloplast leverede en organisk vækst på 8% og en overskudsgrad på 28% i tredje kvartal1). Den rapporterede omsætning målt i...
July 07, 2023 02:26 ET | Source: Coloplast A/S

Coloplast A/S - Announcement no. 03/2023 - Coloplast announces agreement to acquire Kerecis and raises long-term growth expectations

Coloplast has signed an agreement to acquire Kerecis, an innovative, fast-growing company in the biologics wound care segment, for up to USD 1.3 billion (around DKK 8.9 billion), of which USD 1.2...
July 07, 2023 02:26 ET | Source: Coloplast A/S

Coloplast A/S - Selskabsmeddelelse nr. 03/2023 - Coloplast offentliggør aftale om køb af Kerecis og hæver de langsigtede vækstforventninger

Coloplast har indgået en aftale om at købe Kerecis, en innovativ og hurtigtvoksende virksomhed inden for ’biologics’ sårplejesegmentet, for op til USD 1,3 mia. (omkring 8,9 mia. kr.), hvoraf USD 1,2...
June 21, 2023 12:05 ET | Source: Coloplast A/S

Largest shareholder and Foundation to secure Coloplast future with new holding company

As part of a generational change, the largest shareholder in Coloplast A/S, Niels Peter Louis-Hansen, will establish a new holding company. The company will be co-founded with Coloplast’s...
June 21, 2023 12:05 ET | Source: Coloplast A/S

Hovedaktionær og Fond vil sikre Coloplast med nyt holdingselskab

Hovedaktionær i Coloplast A/S, Niels Peter Louis-Hansen, vil som led i et generationsskifte stifte et holdingselskab. Selskabet stiftes sammen med Coloplasts næststørste aktionær Aage og Johanne...
May 11, 2023 01:30 ET | Source: Coloplast A/S

Coloplast A/S - Announcement no. 02/2023 - Interim Financial Report, H1 2022/23

H1 2022/23 Interim financial results, H1 2022/23 1 October 2022 - 31 March 2023 Coloplast delivered Q2 organic growth of 8% and 28% EBIT margin1). Reported revenue in DKK was up by 10%. ...
May 11, 2023 01:30 ET | Source: Coloplast A/S

Coloplast A/S - Selskabsmeddelelse nr. 02/2023 - Regnskabsmeddelelse, 1. halvår 2022/23

H1 2022/23 Regnskabsmeddelelse, 1. halvår 2022/23 1. oktober 2022 – 31. marts 2023 Coloplast leverede en organisk vækst på 8% og en overskudsgrad på 28% i andet kvartal1). Den...
April 24, 2023 03:30 ET | Source: Coloplast A/S

New clinical study demonstrates significant improvement in pulmonary health and related symptoms when using Provox® Life™

A new multi-center, prospective, two-phase clinical trial1 supported by Atos Medical, a leading company in laryngectomy care, demonstrates a significant improvement in cough and sputum symptoms,...
March 31, 2023 01:55 ET | Source: Coloplast A/S

Study shows significant improvement in bladder emptying with Coloplast's Luja™ compared to competitor catheter

Study results show that Coloplast’s new intermittent male catheter with 80+ micro-holes, Luja, achieved complete bladder emptying in one free flow* in 90% of catheterisations, while Hollister’s...
March 31, 2023 01:55 ET | Source: Coloplast A/S

Studie viser signifikant forbedring af blæretømning med Coloplasts Luja™ sammenlignet med konkurrentkateter

Studieresultater viser, at Coloplasts nye engangskateter med mere end 80 mikrohuller, Luja, opnåede fuldstændig blæretømning i frit flow* i 90% af kateteriseringerne, mens Hollister’s VaPro™ med to...